Immunyx Pharma

Immunyx is a drug development company focused on modulating neutrophil function in disease. They are developing a targeted neutrophil nanoparticle platform (TENNs) to address challenges in neutrophil therapy, aiming to provide effective and safe treatments for deregulated neutrophil damage in diseases like COPD, cancer, colitis, and arthritis. Their technology aims to modify neutrophil toxicity without causing neutropenia.